Rosuvastatin in diabetic hemodialysis patients.

@article{Holdaas2011RosuvastatinID,
  title={Rosuvastatin in diabetic hemodialysis patients.},
  author={Hallvard Holdaas and Ingar Holme and Roland E Schmieder and Alan Jardine and Fa{\"i}ez Zannad and Gudrun E Norby and Bengt C. Fellstr{\"o}m},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2011},
  volume={22 7},
  pages={1335-41}
}
A randomized, placebo-controlled trial in diabetic patients receiving hemodialysis showed no effect of atorvastatin on a composite cardiovascular endpoint, but analysis of the component cardiac endpoints suggested that atorvastatin may significantly reduce risk. Because the AURORA (A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events) trial included patients with and without diabetes, we conducted a post hoc… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 46 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

ALERT study group: Inflammation in renal transplantation

  • S Abedini, I Holme, +9 authors H Holdaas
  • Clin J Am Soc Nephrol
  • 2009
1 Excerpt

Cholesterol Treatment Trialists

  • Collaborators, PM Kearney, +6 authors C Baigent
  • Lancet 371:
  • 2008

Similar Papers

Loading similar papers…